In addition to its massive booth at Pittcon 2006, Agilent also held a press briefing to announce the launch of several new products related to its mass spec and liquid chromatography lines. In particular, the firm highlighted its new 1200 Series LC and 6000 Series LC/MS platform, which includes two mass spectrometers that have yet to be shipped.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.